Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle K Payne

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Immunological Investigations|September 13, 2016
Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracyKyle K Payne
Seminars in Cancer Biology|June 7, 2021
Cellular stress responses and metabolic reprogramming in cancer progression and dormancyKyle K Payne
Immunological Investigations|October 25, 2016
Immune Regulatory Function of TregsMasoud H Manjili, Kyle K Payne
Oncoimmunology|June 22, 2012
Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systemsMasoud H Manjili, Kyle K Payne
Archivum Immunologiae Et Therapiae Experimentalis|August 23, 2012
Adaptive immune responses associated with breast cancer relapseKyle K Payne, Masoud H Manjili
Discovery Medicine|July 16, 2015
Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?Masoud H Manjili, Kyle K Payne
Future Oncology (London, England)|October 11, 2014
Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacyKyle K Payne, Harry D Bear, Masoud H Manjili
Oncoscience|May 10, 2017
Estrogens drive myeloid-derived suppressor cell accumulationJose R Conejo-Garcia, Kyle K Payne, Nikolaos Svoronos
Journal of Leukocyte Biology|November 23, 2007
Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cellsTina L Sumpter, Kyle K Payne, David S Wilkes
Oncoimmunology|December 19, 2013
HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastomaMadhu Gowda, Kyle K Payne, Kamar Godder, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Immunological Investigations|September 13, 2016
Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracyKyle K Payne
Seminars in Cancer Biology|June 7, 2021
Cellular stress responses and metabolic reprogramming in cancer progression and dormancyKyle K Payne
Immunological Investigations|October 25, 2016
Immune Regulatory Function of TregsMasoud H Manjili, Kyle K Payne
Oncoimmunology|June 22, 2012
Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systemsMasoud H Manjili, Kyle K Payne
Archivum Immunologiae Et Therapiae Experimentalis|August 23, 2012
Adaptive immune responses associated with breast cancer relapseKyle K Payne, Masoud H Manjili
Discovery Medicine|July 16, 2015
Prospects in cancer immunotherapy: treating advanced stage disease or preventing tumor recurrence?Masoud H Manjili, Kyle K Payne
Future Oncology (London, England)|October 11, 2014
Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacyKyle K Payne, Harry D Bear, Masoud H Manjili
Oncoscience|May 10, 2017
Estrogens drive myeloid-derived suppressor cell accumulationJose R Conejo-Garcia, Kyle K Payne, Nikolaos Svoronos
Journal of Leukocyte Biology|November 23, 2007
Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cellsTina L Sumpter, Kyle K Payne, David S Wilkes
Oncoimmunology|December 19, 2013
HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastomaMadhu Gowda, Kyle K Payne, Kamar Godder, et al.
Pageof 5